Eye Melanoma Unveiled

Dr. Bhupendra Gopalbhai Prajapati is Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India, and serves as Adjunct Professor in the Department of Industrial Pharmacy at Silpakorn University, Thailand. His academic, research, and industry expertise focuses on lipid‑based formulations, nano‑ and microparticulate drug delivery systems, and strategies to enhance drug bioavailability. Dr. Prajapati has received several academic and professional honors recognizing excellence in teaching and research. He has made substantial scholarly contributions through research and review publications, book chapters, and edited volumes in pharmaceutical sciences. Actively engaged in postgraduate and doctoral mentoring, he supports research training in advanced drug delivery and formulation science. Dr. Prajapati also serves in editorial and section‑editor roles for international scientific publications, contributing to the advancement and quality of pharmaceutical research dissemination. Dr. Devesh U. Kapoor is Professor of Pharmaceutics at Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, affiliated with Gujarat Technological University. His academic and research expertise centers on pharmaceutics, nanodrug delivery, and modified‑release drug delivery systems. Dr. Kapoor has made extensive scholarly contributions through research and review publications, book chapters, and edited volumes with international publishers. He is actively involved in postgraduate and doctoral research supervision in advanced drug delivery technologies. His editorial experience includes serving in senior editorial roles for international journals across pharmacology, pharmaceutics, and biomedical sciences, along with regular peer‑review activity for a wide range of scientific journals. Dr. Kapoor has also secured competitive research and academic development funding and is a frequent invited speaker at national scientific meetings, workshops, and academic programs. Currently working as an Assistant Professor in the Department of Pharmacology and Toxicology at College of Pharmacy King Saud University, Riyadh Saudi Arabia. Before joining King Saud University worked as a Post-Doctoral Scholar in the School of Medicine, University of Kentucky, Lexington, USA.. Currently involved in teaching, research, and research is mainly focused on finding the molecular mechanisms involved in cancer chemoprevention and chemotherapy-induced vital organ toxicity and their prevention using natural and synthetic compounds using in-vivo and in-vitro models. He has published more than 130 research, review and book chapters in highly reputed international journals.

• Chapter 1: Introduction to eye melanoma: Pathogenesis, diagnosis, and current treatment modalitiesPavithra Kothapalli, Manimaran Vasanthan and Devesh U KapoorChapter 2: Eye melanoma: Epidemiology and risk factorsShama Mujawar, Durairaj Vijayasarathi, Tanishqa Annam, Tanaya Deshpande, Abha Prabhune, Aarohi Deshpande and Bhupendra G. PrajapatiChapter 3: Fundamentals of nano drug delivery systems: Principles and applications in ocular oncologyBiswajit Basu, Monosiz Rahaman and Bhupendra G. PrajapatiChapter 4: Diagnostic nanoprobes for early detection and monitoring of eye melanoma progressionLucy Mohapatra, Ayushi Singh, Deepak Mishra, Alok S Tripathi, Sambit Kumar Parida and Bhupendra G. PrajapatiChapter 5: Liposomal formulation for the diagnosis and treatment of eye melanomaBiswajit Basu, Monosiz Rahaman and Bhupendra G. PrajapatiChapter 6: Polymeric nanoparticles for the diagnosis and treatment of eye melanomaKavyashree Shetty and Saritha ShettyChapter 7: Role of hydrogel for the diagnosis and treatment of eye melanomaAnindita De, Marjita Chakma, Kanika Singh, Shivam Singh and Young Joon ParkChapter 8: Application of quantum dots for the diagnosis and treatment of eye melanomaHimanshu Paliwal, Akanksha Kasture, Pratiksha Khedkar, Tejas Rangbhal and Bhupendra G. PrajapatiChapter 9: Nanoscale drug-eluting implants for the diagnosis and treatment of eye melanomaAkruti Khodakiya, Chelsi Gadhvi, Bhupendra G. Prajapati and Ashish WadhwaniChapter 10: Nanoparticles conjugated with targeting ligands for the diagnosis and treatment of eye melanomaNidhi Trivedi, Vidhi Pandya, Amit A. Patel, Viral A. Patel, Bhupendra G. Prajapati, Samir G. Patel and Ravish J. PatelChapter 11: Treatment modalities: Surgery and radiotherapy for eye melanomaSridevi S, Dhivya L. S, Ankul Singh. S, Monisha A, Harikrishnan N and Bhupendra G. PrajapatiChapter 12: Emerging therapies: Targeted and immunotherapy for eye melanomaNeelakanta Sarvashiva Kiran, Chandrashekar Yashaswini, Ankita Chatterjee and Bhupendra G. PrajapatiChapter 13: Biomarkers for detection of eye melanomaRanjan Kumar Singh, Chennu M.M Prasada Rao, Vaibhav Saxena, Komal Sharma, Vivek Jain, Rajeswari Tanniru and Devesh U. KapoorChapter 14: Eye melanoma: Management of metastatic diseaseMayur B. Kale, Nitu L. Wankhede, Rupali S. Pawar, Aman B. Upaganlawar, Brijesh G. Taksande, Milind J. Umekar, Sushruta Koppula and Spandana Rajendra KopalliChapter 15: Precision medication in therapy of eye melanomaNeelakanta Sarvashiva Kiran, Chandrashekar Yashaswini, Ankita Chatterjee and Bhupendra G. Prajapati